Dr. Guojun Zhang 张国君
Oncology
Yunnan Cancer Hospital, Kunming
Public profile Compiled from public sources. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Breast-conserving and reconstructive surgery for breast cancer Molecular imaging-guided tumor surgery navigation Neoadjuvant therapy for breast cancer Localization and excision of small breast lesions Individualized comprehensive management of breast cancer Precision diagnosis and treatment of breast cancer
Conditions and procedures: Breast cancer, Small breast lesions
Compiled from public information; not confirmed with the hospital or the doctor.
Name order: in Chinese the family name comes first (Zhang Guojun). Papers usually list the name as Guojun Zhang.
Selected publications
14 first- or senior-author papers on PubMed where the author's own affiliation is this hospital (14 since 2016). Most recent:
- Cancer Lett, 2026 (senior author): GSH-activatable rare-earth nanoprobe for NIR-II fluorescence imaging-guided surgery and enhanced chemotherapy/chemodynamic therapy of breast cancer. PubMed 42276408
- Breast Cancer Res, 2026 (senior author): Preoperative prediction of positive margins in breast-conserving surgery using an ensemble model based on DCE-MRI: a multi-center retrospective and prospective study. PubMed 42902311
- Med Image Anal, 2026 (senior author): Predicting neoadjuvant therapy response in breast cancer from preoperative biopsy via spatial-semantic-differential learning and interpretable clinicopathological-guided fusion. PubMed 41934741
- Cancer Lett, 2026 (senior author): A NIR-Ⅱ fluorescent probe for real-time visualization and early assessment of responses to CDK4/6 inhibitors in breast cancer. PubMed 41825845
- Proc Natl Acad Sci U S A, 2026 (senior author): TROP2-targeted NIR-II fluorescence imaging for visualizing surgical margins and metastatic sentinel lymph nodes in breast cancers. PubMed 41712645
- Int J Surg, 2026 (senior author): Intraoperative evaluation of metastatic SLNs with NIRF imaging assisted by artificial intelligence in breast cancers. PubMed 41085673
- Cancer Cell Int, 2025 (senior author): Prognostic value of a lncRNA signature in early-stage invasive breast cancer patients. PubMed 40556001
- Cancer Biol Med, 2025 (senior author): The treatment of breast cancer in the era of precision medicine. PubMed 40269562
Each paper was checked automatically: the author listed with this name must give this hospital as their affiliation. See the full PubMed search.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and recommend a treatment plan.
Get a specialist opinion